Continued media coverage on OHSU and Legacy Health's announcement they have signed a nonbinding letter of intent to combine and create a comprehensive, integrated health system that will offer high-quality, essential health care services to patients throughout Oregon, the Pacific Northwest and beyond.

Andrew Ahmann, M.D., writes an op-ed for the Portland Tribune urging the Oregon Health Authority to "level the playing field", allowing diabetes patients on Medicaid to attain this Continuous Glucose Monitor (CGM) by matching Medicare policy and recommendations from multiple informed national organizations.

While discussing light therapy, also known as phototherapy, as a proven treatment for the dermatological condition psoriasis, Teri M. Greiling, M.D., Ph.D., notes the treatment can cause temporary itching and sunburnt skin.

Continued media coverage on OHSU and Legacy Health's announcement they have signed a nonbinding letter of intent to combine and create a comprehensive, integrated health system that will offer high-quality, essential health care services to patients throughout Oregon, the Pacific Northwest and beyond.

The Portland Business Journal reports that OHSU is proposing to spend $3 million on a safety study and security measures as part of its latest contract offer to the Oregon Nurses Association.

Christopher Slatore, M.D., will serve on the project engagement advisory board for a new Patient-Centered Outcomes Research Institute (PCORI) project designed to build capacity and patient engagement within a "stigmatized lung cancer community."

Two OHSU employees, Liz Marx and Robin Shrout, R.N., joined a Hood to Coast relay team named "Will Power" in honor of Will Krajewski, who passed away from cancer at 17 years old. Marx says: "I think first I want to thank him (Will). I think I'm braver because of him."

A study by Eric Simpson, M.D., found using the monoclonal antibody dupilumab reduced Staphylococcus aureus infection in patients with atopic dermatitis.

Koneksa, a healthcare technology company, announces a collaboration with OHSU to enable the inclusion of app-and actigraphy-based digital measures and electronic patient-reported outcome (ePRO) instruments from Koneksa’s Neuroscience Toolkit into a study comparing short-acting versus long-acting levodopa in Parkinson’s disease.

In a New York Times story illustrating the use of mental health care increased substantially during the pandemic, Jane Zhu, M.D., says insurers will have to determine whether telehealth is preventing patients from accessing more expensive forms of care, like using emergency rooms for mental health crises. She says: “It will trickle down at some point. It will either mean that total spending is going to go up, if there’s a lot of people using telehealth, or insurers are going to be looking for ways to reduce their spending.”